MedPath
HSA Approval

MOXIFCIN FILM COATED TABLET 400MG

SIN17209P

MOXIFCIN FILM COATED TABLET 400MG

MOXIFCIN FILM COATED TABLET 400MG

March 18, 2025

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J01MA14

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Y.S.P. Industries (M) Sdn. Bhd.

Active Ingredients

Moxifloxacin Hydrochloride eqv Moxifloxacin

400mg

Moxifloxacin

Documents

Package Inserts

MOXIFCIN FILM-COATED TABLET PI.pdf

Approved: March 18, 2025

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MOXIFCIN FILM COATED TABLET 400MG - HSA Approval | MedPath